Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Fibrosis | 6 | 2024 | 96 | 3.190 |
Why?
|
| Syndecan-2 | 5 | 2022 | 14 | 2.410 |
Why?
|
| Heme Oxygenase-1 | 9 | 2014 | 34 | 1.920 |
Why?
|
| Sepsis | 9 | 2021 | 478 | 1.670 |
Why?
|
| Fibroblasts | 7 | 2024 | 877 | 1.630 |
Why?
|
| Carbon Monoxide | 5 | 2017 | 27 | 1.610 |
Why?
|
| Lipopolysaccharides | 8 | 2013 | 291 | 1.440 |
Why?
|
| Nitric Oxide Synthase Type II | 8 | 2013 | 94 | 1.440 |
Why?
|
| Lung Injury | 2 | 2022 | 118 | 1.430 |
Why?
|
| HMGB1 Protein | 7 | 2013 | 33 | 1.370 |
Why?
|
| Cyclooxygenase 2 | 5 | 2010 | 158 | 1.330 |
Why?
|
| Radiation Injuries | 2 | 2022 | 142 | 1.260 |
Why?
|
| Macrophages | 9 | 2021 | 607 | 1.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 8 | 2022 | 342 | 1.150 |
Why?
|
| Tetrahydroisoquinolines | 6 | 2014 | 11 | 1.050 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 3 | 2023 | 112 | 1.050 |
Why?
|
| Lung | 8 | 2024 | 1468 | 1.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2024 | 131 | 1.010 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2013 | 279 | 0.930 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2022 | 491 | 0.870 |
Why?
|
| Fibrosis | 1 | 2024 | 429 | 0.820 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 261 | 0.800 |
Why?
|
| Bleomycin | 4 | 2024 | 150 | 0.780 |
Why?
|
| Organometallic Compounds | 3 | 2010 | 106 | 0.760 |
Why?
|
| Mice | 29 | 2024 | 17469 | 0.720 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2014 | 269 | 0.700 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2010 | 63 | 0.680 |
Why?
|
| Janus Kinase 2 | 3 | 2010 | 136 | 0.670 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2010 | 133 | 0.670 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2021 | 78 | 0.670 |
Why?
|
| Anthocyanins | 2 | 2008 | 4 | 0.640 |
Why?
|
| Gene Expression Regulation | 5 | 2022 | 2533 | 0.610 |
Why?
|
| Animals | 32 | 2024 | 33693 | 0.600 |
Why?
|
| Ultraviolet Rays | 2 | 2008 | 204 | 0.590 |
Why?
|
| NF-kappa B | 5 | 2021 | 459 | 0.570 |
Why?
|
| Phagocytosis | 4 | 2021 | 170 | 0.560 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 3 | 2022 | 10 | 0.550 |
Why?
|
| Membrane Proteins | 4 | 2014 | 1524 | 0.540 |
Why?
|
| Endotoxemia | 3 | 2011 | 56 | 0.520 |
Why?
|
| Mice, Inbred BALB C | 7 | 2020 | 1002 | 0.480 |
Why?
|
| Cell Line | 9 | 2014 | 2779 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2014 | 55 | 0.470 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2014 | 670 | 0.460 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 110 | 0.450 |
Why?
|
| Nitric Oxide | 4 | 2011 | 432 | 0.450 |
Why?
|
| Lipids | 1 | 2016 | 513 | 0.440 |
Why?
|
| Interferon-beta | 2 | 2010 | 50 | 0.430 |
Why?
|
| Inflammation | 3 | 2021 | 1400 | 0.410 |
Why?
|
| Citrullination | 2 | 2022 | 6 | 0.390 |
Why?
|
| Cyperus | 1 | 2011 | 1 | 0.390 |
Why?
|
| Seeds | 2 | 2008 | 42 | 0.390 |
Why?
|
| Macrophages, Alveolar | 2 | 2020 | 43 | 0.380 |
Why?
|
| Sesquiterpenes | 1 | 2011 | 22 | 0.380 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 256 | 0.380 |
Why?
|
| Dinoprostone | 2 | 2008 | 76 | 0.380 |
Why?
|
| Myofibroblasts | 2 | 2024 | 75 | 0.370 |
Why?
|
| Nicotinic Agonists | 1 | 2011 | 44 | 0.370 |
Why?
|
| STAT1 Transcription Factor | 2 | 2008 | 69 | 0.370 |
Why?
|
| GATA6 Transcription Factor | 1 | 2010 | 10 | 0.360 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 64 | 0.350 |
Why?
|
| Plant Extracts | 1 | 2011 | 120 | 0.350 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 154 | 0.340 |
Why?
|
| Nicotine | 1 | 2011 | 140 | 0.340 |
Why?
|
| Skin | 3 | 2024 | 505 | 0.340 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1581 | 0.330 |
Why?
|
| PPAR gamma | 1 | 2009 | 91 | 0.330 |
Why?
|
| Metformin | 1 | 2011 | 148 | 0.320 |
Why?
|
| Caspase Inhibitors | 1 | 2008 | 29 | 0.320 |
Why?
|
| Transfection | 4 | 2014 | 1068 | 0.320 |
Why?
|
| Cell Adhesion | 1 | 2009 | 321 | 0.310 |
Why?
|
| Macrophage Activation | 1 | 2008 | 61 | 0.310 |
Why?
|
| Signal Transduction | 8 | 2021 | 4507 | 0.280 |
Why?
|
| Enzyme Activation | 2 | 2024 | 619 | 0.280 |
Why?
|
| Up-Regulation | 3 | 2019 | 867 | 0.280 |
Why?
|
| Gene Silencing | 3 | 2021 | 237 | 0.270 |
Why?
|
| Pyrimidines | 2 | 2024 | 374 | 0.260 |
Why?
|
| Cells, Cultured | 7 | 2024 | 3050 | 0.260 |
Why?
|
| Autophagy | 2 | 2021 | 390 | 0.260 |
Why?
|
| Endothelial Cells | 1 | 2009 | 528 | 0.250 |
Why?
|
| Apoptosis | 3 | 2019 | 1783 | 0.240 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 2391 | 0.230 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 4263 | 0.230 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2024 | 127 | 0.230 |
Why?
|
| Humans | 19 | 2024 | 122998 | 0.220 |
Why?
|
| Scleroderma, Systemic | 1 | 2024 | 117 | 0.220 |
Why?
|
| Sarcoidosis | 1 | 2023 | 63 | 0.210 |
Why?
|
| Pyridines | 1 | 2024 | 222 | 0.210 |
Why?
|
| Macular Degeneration | 1 | 2024 | 112 | 0.210 |
Why?
|
| Mice, Knockout | 4 | 2021 | 3710 | 0.210 |
Why?
|
| Cell Survival | 4 | 2020 | 803 | 0.200 |
Why?
|
| RNA Interference | 4 | 2013 | 496 | 0.200 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2022 | 4 | 0.200 |
Why?
|
| Sp1 Transcription Factor | 1 | 2022 | 43 | 0.200 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 147 | 0.200 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2021 | 428 | 0.190 |
Why?
|
| Elastic Tissue | 1 | 2021 | 19 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2014 | 1684 | 0.190 |
Why?
|
| Cell Proliferation | 2 | 2019 | 2306 | 0.190 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 101 | 0.190 |
Why?
|
| Phosphorylation | 3 | 2010 | 1610 | 0.190 |
Why?
|
| Cell Movement | 3 | 2024 | 831 | 0.180 |
Why?
|
| Extracellular Vesicles | 1 | 2021 | 45 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 149 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 396 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2021 | 127 | 0.180 |
Why?
|
| Blotting, Western | 2 | 2014 | 1102 | 0.180 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 33 | 0.170 |
Why?
|
| Palmitic Acid | 1 | 2019 | 35 | 0.170 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 966 | 0.170 |
Why?
|
| Syntenins | 1 | 2019 | 2 | 0.170 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 51 | 0.170 |
Why?
|
| Neutrophils | 3 | 2021 | 372 | 0.170 |
Why?
|
| Cryopreservation | 1 | 2020 | 82 | 0.170 |
Why?
|
| Protein Kinase C | 2 | 2011 | 150 | 0.170 |
Why?
|
| A549 Cells | 1 | 2019 | 44 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 1874 | 0.160 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 53 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2019 | 121 | 0.160 |
Why?
|
| Mice, Hairless | 2 | 2008 | 30 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2019 | 137 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4342 | 0.160 |
Why?
|
| Keratinocytes | 2 | 2008 | 59 | 0.150 |
Why?
|
| Enzyme Inhibitors | 3 | 2013 | 571 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 208 | 0.150 |
Why?
|
| Mice, SCID | 1 | 2019 | 571 | 0.150 |
Why?
|
| Thorax | 1 | 2018 | 72 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 1390 | 0.150 |
Why?
|
| rho-Associated Kinases | 1 | 2018 | 55 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2021 | 747 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 602 | 0.140 |
Why?
|
| Autophagy-Related Proteins | 1 | 2017 | 31 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1915 | 0.140 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 481 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2013 | 102 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2019 | 674 | 0.140 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 663 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 456 | 0.120 |
Why?
|
| Cytokines | 2 | 2011 | 1280 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 239 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 317 | 0.110 |
Why?
|
| Phenotype | 2 | 2021 | 4221 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2014 | 122 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 79 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2013 | 165 | 0.110 |
Why?
|
| Protein-Arginine Deiminases | 2 | 2023 | 6 | 0.110 |
Why?
|
| Dermatologic Agents | 1 | 2013 | 30 | 0.110 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 191 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 515 | 0.100 |
Why?
|
| Wounds, Penetrating | 1 | 2013 | 139 | 0.100 |
Why?
|
| Male | 9 | 2024 | 59901 | 0.100 |
Why?
|
| Mitochondria | 1 | 2017 | 682 | 0.100 |
Why?
|
| Rhizome | 1 | 2011 | 1 | 0.100 |
Why?
|
| Plants, Medicinal | 1 | 2011 | 23 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2017 | 796 | 0.100 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 147 | 0.090 |
Why?
|
| Peptidoglycan | 1 | 2010 | 16 | 0.090 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2011 | 57 | 0.090 |
Why?
|
| Peroxidase | 1 | 2011 | 61 | 0.090 |
Why?
|
| Poly I-C | 1 | 2010 | 22 | 0.090 |
Why?
|
| Glutathione | 1 | 2012 | 193 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 57 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 414 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 115 | 0.090 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 84 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 160 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2023 | 354 | 0.090 |
Why?
|
| Time Factors | 2 | 2011 | 6198 | 0.090 |
Why?
|
| Survival Rate | 2 | 2013 | 1993 | 0.080 |
Why?
|
| U937 Cells | 1 | 2009 | 26 | 0.080 |
Why?
|
| Protoporphyrins | 1 | 2009 | 8 | 0.080 |
Why?
|
| Hemin | 1 | 2009 | 17 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2011 | 241 | 0.080 |
Why?
|
| Wound Healing | 1 | 2013 | 451 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2009 | 112 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 170 | 0.080 |
Why?
|
| Bacteremia | 1 | 2013 | 406 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2011 | 302 | 0.080 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 60 | 0.080 |
Why?
|
| Alkaloids | 1 | 2008 | 33 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1005 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2009 | 288 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 207 | 0.070 |
Why?
|
| TYK2 Kinase | 1 | 2006 | 6 | 0.070 |
Why?
|
| Monocytes | 1 | 2009 | 347 | 0.070 |
Why?
|
| Isoquinolines | 1 | 2006 | 40 | 0.070 |
Why?
|
| Naphthalenes | 1 | 2006 | 37 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1211 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 1675 | 0.060 |
Why?
|
| Basigin | 1 | 2024 | 14 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 516 | 0.060 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 87 | 0.060 |
Why?
|
| Gene Expression | 1 | 2008 | 1569 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2024 | 240 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 197 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1442 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 210 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 172 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 3629 | 0.050 |
Why?
|
| Female | 3 | 2018 | 65310 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2021 | 71 | 0.050 |
Why?
|
| Peptides | 1 | 2024 | 798 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2023 | 511 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2021 | 125 | 0.050 |
Why?
|
| Immunity | 1 | 2021 | 183 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 327 | 0.040 |
Why?
|
| CD36 Antigens | 1 | 2019 | 35 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2020 | 357 | 0.040 |
Why?
|
| Proteins | 1 | 2023 | 1038 | 0.040 |
Why?
|
| Proteomics | 1 | 2021 | 480 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 51 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2017 | 48 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 996 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 286 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 900 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2014 | 31 | 0.030 |
Why?
|
| I-kappa B Kinase | 1 | 2014 | 60 | 0.030 |
Why?
|
| Antioxidants | 1 | 2017 | 337 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 131 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 240 | 0.030 |
Why?
|
| Cecum | 1 | 2013 | 27 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 423 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 258 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3283 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2006 | 103 | 0.020 |
Why?
|